Resilience

Mwe Lifesciences LLC, located in La Jolla, CA, specializes in the development of next-generation biosensors aimed at enhancing diagnostic capabilities. Their innovative approach is designed to improve the accuracy and efficiency of medical diagnostics. Operating under the brand BlueArc Biosciences, the company is committed to advancing healthcare technology through cutting-edge research and development. Their focus on biosciences positions them as a key player in the field of diagnostics. Generated from the website

The La Jolla Institute for Immunology is a leading research organization dedicated to unraveling the complexities of the immune system to tackle a diverse array of diseases, including cancer, autoimmune conditions, and infectious diseases. With a focus on innovative research, the institute is home to several specialized centers that collaborate to accelerate the development of new treatments and vaccines. Generated from the website

Longboard Pharmaceuticals delivers medicines with optimized pharmacology and pharmacokinetics to patients with rare neurological diseases. Its proprietary pipeline includes multiple programs with broad clinical utility. Longboard is evaluating LP352, a next-generation 5-HT2C agonist, in development for the potential treatment of developmental and epileptic encephalopathies, or DEEs. Longboard is also evaluating LP143, a centrally acting, full agonist of the cannabinoid type 2 receptor (CB2), and LP659, a centrally acting, next-generation, highly selective S1P receptor modulator.